- Home
- SWBI vs TERN Comparison
SWBI vs TERN Comparison
Compare SWBI & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- TERN
- Stock Information
- Founded
- SWBI 1852
- TERN 2017
- Country
- SWBI United States
- TERN United States
- Employees
- SWBI N/A
- TERN N/A
- Industry
- SWBI Ordnance And Accessories
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- SWBI Industrials
- TERN Health Care
- Exchange
- SWBI Nasdaq
- TERN Nasdaq
- Market Cap
- SWBI 587.1M
- TERN 586.0M
- IPO Year
- SWBI N/A
- TERN 2021
- Fundamental
- Price
- SWBI $13.37
- TERN $5.79
- Analyst Decision
- SWBI Strong Buy
- TERN Buy
- Analyst Count
- SWBI 2
- TERN 6
- Target Price
- SWBI $18.00
- TERN $16.42
- AVG Volume (30 Days)
- SWBI 503.0K
- TERN 1.3M
- Earning Date
- SWBI 12-05-2024
- TERN 11-12-2024
- Dividend Yield
- SWBI 3.89%
- TERN N/A
- EPS Growth
- SWBI N/A
- TERN N/A
- EPS
- SWBI 0.75
- TERN N/A
- Revenue
- SWBI $509,924,000.00
- TERN N/A
- Revenue This Year
- SWBI $6.69
- TERN N/A
- Revenue Next Year
- SWBI $6.31
- TERN N/A
- P/E Ratio
- SWBI $17.93
- TERN N/A
- Revenue Growth
- SWBI 0.16
- TERN N/A
- 52 Week Low
- SWBI $11.96
- TERN $3.59
- 52 Week High
- SWBI $18.05
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- SWBI 52.82
- TERN 33.20
- Support Level
- SWBI $12.87
- TERN $5.46
- Resistance Level
- SWBI $13.22
- TERN $7.53
- Average True Range (ATR)
- SWBI 0.43
- TERN 0.44
- MACD
- SWBI 0.00
- TERN -0.09
- Stochastic Oscillator
- SWBI 60.54
- TERN 15.21
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.